James McKay
Rheumatology · Tulsa, OKNPI 1205840436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for rheumatology clinicians in OK, where the typical reported total is $4,359.
Across 313 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$721
- AbbVie$716
- Mallinckrodt Hospital Products Inc.$440
- Lilly USA, LLC$380
- Genentech USA, Inc.$370
- UCB, Inc.$309
- plus $2K from 13 others
Across 80 payments — averaging $11,753 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$585K
- Gilead$211K
- Amgen$84K
- Astrazeneca UK Limited$41K
- GSK$19K
What the payments were for
- Food & beverage$4,685100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 47 | $721 |
| AbbVie | 48 | $716 |
| Mallinckrodt Hospital Products Inc. | 21 | $440 |
| Lilly USA, LLC | 22 | $380 |
| Genentech USA, Inc. | 27 | $370 |
| UCB, Inc. | 21 | $309 |
| Johnson & Johnson | 29 | $289 |
| E.r. Squibb & Sons, L.L.C. | 18 | $284 |
| Mallinckrodt Enterprises LLC | 15 | $263 |
| GSK | 20 | $250 |
| Pfizer | 18 | $182 |
| Radius Health, Inc. | 9 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
| Bristol Myers Squibb | 5 | $89 |
| Aurinia Pharma U.S., Inc. | 4 | $76 |
| Novartis | 2 | $22 |
| Medtronic | 1 | $18 |
| AstraZeneca | 1 | $12 |
| Actelion Pharmaceuticals US, Inc. | 1 | $5 |
How this compares
$4,685 in reported general payments places this provider in the 50th percentile of 67 rheumatology providers in Oklahoma.
Other rheumatology in Tulsa
- Debbie FoleyTulsa$281K
- Mary Hinojos MamutTulsa$21K
- Manuel CalvinTulsa$19K
- Alan MartinTulsa$18K
- William SurbeckTulsa$17K
- Michael MalloyTulsa$13K
- Ellen ZanetakisTulsa$10K
- Basmah JalilTulsa$10K
- Priyatha GarlapatiTulsa$8K
- Lindsay CunninghamTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.